Biggs HM, Nix WA, Zhang J, et al. Enterovirus D68 infection among hospitalized children with severe acute respiratory illness in El Salvador and Panama, 2012‐2013. Influenza Other Respir Dis 2020 (published online Dec 5)
Fall A, Ndiaye N, Messacar K, et al. Enterovirus D68 subclade B3 in children with acute flaccid paralysis in West Africa, 2016. Emerg Infect Dis 2020 Sep;26(9)
Gao J, Tang F, Wang Z, et al. Post-marketing safety surveillance for inactivated Enterovirus 71 vaccines in Jiangsu, China from 2017 to 2019. Vaccine 2021 (published online Feb 1)
Ikuse T, Aizawa Y, Yamanaka T, et al. Outbreak of enterovirus D68 among children in Japan—worldwide circulation of enterovirus D68 clade B3 in 2018. Pediatr Infect Dis J 2021 Jan;40(1):6-10
Kidd S, Lopez A, Nix WA, et al. Vital signs: clinical characteristics of patients with confirmed acute flaccid myelitis, United States, 2018. MMWR Aug 4;69
Park SW, Pons-Salort M, Messacar K, et al. Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis. Sci Transl Med 2021 Mar 10;13(584)
Pellegrinelli L, Galli C, Primache V, et al. Emerging non-polio enteroviruses recognized in the framework of the acute flaccid paralyses (AFP) surveillance system in Northern Italy, 2016-2018. Int J Infect Dis 2021 (published online Mar 23)
Puenpa J, Chansaenroj J, Auphimai C, et al. Neutralizing antibody against enterovirus-A71 in Thai children: a longitudinal study from birth to age 4 years. Vaccine 1010 (published online Oct 14)
Wang J, Jiang L, Zhang C, et al. The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine. Vaccine 2021 (published online May 14)
Wei X, Yang J, Gao L, et al. The transfer and decay of maternal antibodies against enterovirus A71, and dynamics of antibodies due to later natural infections in Chinese infants: a longitudinal, paired mother–neonate cohort study. Lancet Infect Dis 2020 (published online Oct 5)
